Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 01287 Kollaborative Behandlung | Other Identifier | IFS GmbH |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK) | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The main focus of the pilot study is to evaluate the feasability and effectiveness of a collaborative care intervention for patients suffering from a coronary heart disease (CHD) with insufficient controlled health related risk factors in their lifestyle. The design of the study is a wait list control design. 30 patients will receive treatment immediately after submission, the other 30 after 6 months. An interdisciplinary team, including a care manager for each patient, will offer an individualized treatment plan, based on shared decision making for each patient to reduce risk factors and improve quality of life.
The following assumptions will be evaluated:
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| collaborative care, CHD | Experimental | Participants start with the collaborative care intervention at baseline directly after inclusion. |
|
| collaborative care CHD - waitlist | Active Comparator | Participants start with the intervention 6 months after baseline, in the meantime they receive tau. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| collaborative care CHD | Behavioral | Over a time span of 6 months participants receive individualized treatment to reduce risk factors and improve quality of life, based on their preferences following a health plan, which they developed with their health coach. |
| Measure | Description | Time Frame |
|---|---|---|
| Patients´ satisfaction with treatment between baseline and the up to 12 months follow-up | September 2014: baseline for both groups; first 30 participants start with the Intervention, march 2015: 6-months follow-up for intervention group, participants from the wait list group start with active intervention phase, September 2015: 12-months follow-up intervention group; 6-months follow-up participants wait list group, march 2016: 12-months follow-up participants wait list group | up to 12 months follow-up |
| Change in composite cardiovascular risk score | Change in cardiovascular risk factor score comprised of secondary outcomes mentioned below | Baseline to six months |
| Measure | Description | Time Frame |
|---|---|---|
| Smoking | Actual smoking behavior:yes | Baseline and up to 12 months follow-up |
| Lack of physical exercise | Less than 60 minutes of light physical exercise per week |
| Measure | Description | Time Frame |
|---|---|---|
| Physical strain | Physical strain is measured with the 6-minutes walking test | Baseline and up to 12 months follow-up |
| Fear and depression | Fear and Depression is measured with the HADS-D; Herrmann-Lingen, Buss & Snaith, 1995 |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Christoph Herrmann-Lingen, Prof. Dr. | University of Goettingen, Department of Psychosomatic Medicine and Psychotherapy | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Department of Psychosomatic Medicine and Psychotherapy, Univ. of Goettingen | Göttingen | 37075 | Germany |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 31564125 | Derived | Bosselmann L, Fangauf SV, Herbeck Belnap B, Chavanon ML, Nagel J, Neitzel C, Schertz A, Hummers E, Wachter R, Herrmann-Lingen C. Blended collaborative care in the secondary prevention of coronary heart disease improves risk factor control: Results of a randomised feasibility study. Eur J Cardiovasc Nurs. 2020 Feb;19(2):134-141. doi: 10.1177/1474515119880062. Epub 2019 Sep 28. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D003327 | Coronary Disease |
| D009203 | Myocardial Infarction |
| ID | Term |
|---|---|
| D017202 | Myocardial Ischemia |
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
| D014652 | Vascular Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Baseline and up to 12 months follow-up |
| LDL cholesterol | A LDL value of >130mg/dl or higher | Baseline and up to 12 months follow-up |
| Hypertension | A blood pressure value of >140/90 mmHg or in a 24 hour measurement >135/85 mmHg | Baseline and up to 12 months follow-up |
| Increased HbA1c | A HbA1c value of >7,5% or higher | Baseline and up to 12 months follow-up |
| Heightened level of stress | A value in the PSS-4 >5 is an indicator for an heigtened stress level | Baseline and up to 12 months follow-up |
| Baseline and up to 12 months follow-up |
| Self-efficacy | Self-efficacy is measured with the GSW-6; Romppel et al., 2006 | Baseline and up to 12 months follow-up |
| Social support | Social Support is measured with the ESSI-D, Cordes et al., 2009 | Baseline and up to 12 months follow-up |
| Health-related quality of life | Quality of life is measured with the SF-12, Radoschewski & Bellach,1999 | Baseline and up to 12 months follow-up |
| D007238 |
| Infarction |
| D007511 | Ischemia |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D009336 | Necrosis |